Media

Scientific American

Treating Chronic Pain in the Right Place: Remotely

Dr. David Yarnitsky presents the latest research in neuromodulation and pain mechanisms, which has recently resulted in a new non-pharmacological option for migraine patients.
More
Time

A Year After Approval, Migraine Drugs Are Changing Lives. But Insurance Battles Are Creating a Whole New Headache

An important article in TIME magazine regarding migraine drugs and their…
More
Jerusalem Post

Disrupting the migraine business

Hillel’s Tech corner:Theranica, a biomedical technology company founded in 2016 and based in Netanya that is developing advanced “electroceuticals” – devices that treat ailments with electrical impulses – for…
More
TimeaAZ Family

We’re not the only ones excited about Nerivio!

Happy to see that everyone is just as excited as we are for the Nerivio! It really is a game changer!
More
NeurologyLive

Dr. Brian Grosberg: Nerivio Device for Acute Migraine Treatment

At the American Headache Society’s 2018 Scottsdale Headache Symposium in Arizona, Grosberg sat with NeurologyLive to discuss Nerivio and its potential in the treatment of acute migraine. He noted its comparable outcomes to the pharmacologic acute treatments.
More
MobiHealthNews

Building a future of safe and drug-free alternatives to painkillers

An interview with Alon Ironi, CEO & co-founder of Theranica. Imagine a future where pain can be managed or alleviated using a combination of digital technologies and devices, greatly reducing the risks brought about by conventional painkillers. That is what Alon Ironi, CEO & co-founder of Israel-based biomedical technology company Theranica hopes to achieve.
More
Israel21c

Can an electronic patch reduce the pain of migraines?

It looks like a high-tech version of a nicotine patch, but Theranica Bio-Electronics’ wearable device has a different purpose: to knock out migraines… at least temporarily. Inside Theranica’s Nerivio Migra patch are tiny electrodes that deliver a small electrical jolt to your body to mitigate headaches and other acute pains through what’s known as CPM (conditioned pain modulation).
More
Investing News

Theranica Bioelectronics Hopes to Take Migraine Device Global

Privately owned Theranica Bioelectronics is aiming to reshape the way migraines are treated in patients all around the world. The company, which was founded three years ago, is using advanced neuromodulation therapy with wireless technology to develop electroceuticals for migraines and other pain disorders.
More
Everyday Health

FDA Greenlights New Wearable Device for the Treatment of Acute Migraine

The U.S. Food and Drug Administration (FDA) cleared the way for a first-in-category product that uses remote electrical neuromodulation to treat acute migraine pain. Worn on the upper arm, the smartphone-controlled Nerivio Migra uses electronic pulses to help “turn off” migraine pain.
More
WebMD

FDA OKs Wearable Device for Migraine Pain

May 29, 2019 -- The FDA has cleared a noninvasive device to relieve acute migraine pain. Nerivio Migra is a "first-in-category product," according to Theranica, the company that makes it. It is worn on the upper arm and uses smartphone-controlled electronic pulses to relieve migraine pain.
More
6abc.com

FDA approves wearable migraine pain device

BETHESDA, Md. (WPVI) -- The government has OK'd a new non-invasive device to relieve the pain of acute migraine.
More
MedCity News

Israeli startup gets FDA nod for neuromodulation device to treat migraines

Nerivio Migra consists of a bioelectric patch which is placed on the upper arm and an associated smartphone app which controls the electrical impulses and records data.
More
MassDevice

Omron joins $35m Theranica Series B

Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology. Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review.
More